Aldeyra Therapeutics logo

Aldeyra Therapeutics Share Price (NASDAQ: ALDX)

$5.83

-0.03

(-0.51%)

Last updated on

Check the interactive Aldeyra Therapeutics Stock chart to analyse performance

Aldeyra Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$5.69
    Today's High:$5.89

    Day's Volatility :3.4%

  • 52 Weeks Low:$1.14
    52 Weeks High:$7.20

    52 Weeks Volatility :84.17%

Aldeyra Therapeutics Stock Returns

PeriodAldeyra Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
175.47%
3.6%
0.0%
6 Months
-3.63%
-7.7%
0.0%
1 Year
0.86%
-12.6%
0.0%
3 Years
-18.32%
9.5%
-4.7%

Aldeyra Therapeutics Inc Key Stats

Check Aldeyra Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$5.86
Open
$5.89
Today's High
$5.89
Today's Low
$5.69
Market Capitalization
$351.3M
Today's Volume
$453.3K
52 Week High
$7.2
52 Week Low
$1.14
Revenue TTM
$0.0
EBITDA
$-53.1M
Earnings Per Share (EPS)
$-0.85
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-65.91%

Stock Returns calculator for Aldeyra Therapeutics Stock including INR - Dollar returns

The Aldeyra Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Aldeyra Therapeutics investment value today

Current value as on today

₹1,06,499

Returns

₹6,499

(+6.5%)

Returns from Aldeyra Therapeutics Stock

₹1,215 (+1.22%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Aldeyra Therapeutics Stock

-35%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Aldeyra Therapeutics Stock from India on INDmoney has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Aldeyra Therapeutics Inc

  • Name

    Holdings %

  • Knoll Capital Management LP

    9.12%

  • Perceptive Advisors LLC

    6.75%

  • BlackRock Inc

    6.22%

  • Vanguard Group Inc

    5.83%

  • Ardsley Advisory Partners

    2.91%

  • AQR Capital Management LLC

    2.45%

Analyst Recommendation on Aldeyra Therapeutics Stock

Rating
Trend

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Aldeyra Therapeutics(by analysts ranked 0 to 5 stars)

Aldeyra Therapeutics Share Price Target

What analysts predicted

Upside of 62.95%

Target:

$9.50

Current:

$5.83

Aldeyra Therapeutics share price target is $9.50, a slight Upside of 62.95% compared to current price of $5.83 as per analysts' prediction.

Aldeyra Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, ALDX stock has moved up by 171.6%
  • ALDX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 68.4%
  • ALDX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 130.0%

Aldeyra Therapeutics Technicals Summary

Sell

Neutral

Buy

Aldeyra Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Aldeyra Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Aldeyra Therapeutics Inc logo
17.03%
-3.63%
0.86%
-18.32%
-9.74%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Aldeyra Therapeutics Inc

Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment retinitis pigmentosa. The company also develops ADX-629, an orally administered RASP modulator that is in Phase 2 clinical trials for the treatment of COVID-19, atopic asthma, psoriasis, and alcohol intoxication. In addition, it develops preclinical RASP platform, including ADX 248, ADX 743, ADX 631, ADX 246, and other product candidates in development for inflammatory and metabolic diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.
Organization
Aldeyra Therapeutics
Employees
8
CEO
Dr. Todd C. Brady M.D., Ph.D.
Industry
Health Technology

Key Management of Aldeyra Therapeutics Inc

NameTitle
Dr. Todd C. Brady M.D., Ph.D.
CEO, President & Director
Mr. Michael Alfieri
Head of Finance and Principal Financial & Accounting Officer
Dr. Stephen G. Machatha Ph.D.
Chief Development Officer
David Burke
Head of Investor Relations
Laura Nichols
Operations Manager

Important FAQs about investing in ALDX Stock from India :

What is Aldeyra Therapeutics share price today?

Aldeyra Therapeutics share price today is $5.83 as on at the close of the market. Aldeyra Therapeutics share today touched a day high of $5.89 and a low of $5.69.

What is the 52 week high and 52 week low for Aldeyra Therapeutics share?

Aldeyra Therapeutics share touched a 52 week high of $7.20 and a 52 week low of $1.14. Aldeyra Therapeutics stock price today i.e. is closed at $5.83, lower by 19.03% versus the 52 week high.

How to invest in Aldeyra Therapeutics Stock (ALDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Aldeyra Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aldeyra Therapeutics Shares that will get you 0.2573 shares as per Aldeyra Therapeutics share price of $5.83 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aldeyra Therapeutics Stock (ALDX) from India?

Indian investors can start investing in Aldeyra Therapeutics (ALDX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Aldeyra Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Aldeyra Therapeutics share’s latest price of $5.83 as on August 30, 2025 at 1:29 am IST, you will get 1.7153 shares of Aldeyra Therapeutics. Learn more about fractional shares .

What are the returns that Aldeyra Therapeutics has given to Indian investors in the last 5 years?

Aldeyra Therapeutics stock has given -9.74% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?